These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13729226)

  • 1. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
    NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H
    Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. II. Influences of the low phenylalanine and tyrosine diet upon patients with collagen disease.
    NISHIMURA N; OKAMOTO H; YASUI M; MAEDA K; OGURA K
    Arch Dermatol; 1959 Oct; 80():466-77. PubMed ID: 14427316
    [No Abstract]   [Full Text] [Related]  

  • 3. Tyrosine metabolism in connective tissue disease. P-hydroxyphenylpyruvic acid excretion.
    McCann DS; Mitchell JG; Keech MK; Boyle AJ
    J Chronic Dis; 1967 Oct; 20(10):781-6. PubMed ID: 6080821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specific substance in the urine of patients with collagen disease with special reference to collagen disease and phenylalanine and tyrosine metabolism].
    Nishimura N
    Rinsho Byori; 1966 Nov; 14(11):713-9. PubMed ID: 6009727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary hydroxylysine excretion as an index of systemic collagen disorders].
    Kucharz E; Drózdz M
    Wiad Lek; 1977 May; 30(9):695-700. PubMed ID: 868020
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. I. The presence of 2,5-dihydroxyphenylpyruvic acid in the urine of patients with collagen disease.
    NISHIMURA N; YASUI M; OKAMOTO H; KANAZAWA M; KOTAKE Y; SHIBATA Y
    AMA Arch Derm; 1958 Mar; 77(3):255-62. PubMed ID: 13507702
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors affecting the excretion of metabolites of phenylalanine and tyrosine in alkaptanuria.
    HALL WK; SYDENSTRICKER VP; RAWLS K
    Fed Proc; 1948 Mar; 7(1 Pt 1):289. PubMed ID: 18915877
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical study of malnutrition. Part V. Metabolism of phenylalanine and tyrosine.
    Antener I; Verwilghen AM; van Geert C; Mauron J
    Int J Vitam Nutr Res; 1981; 51(3):297-306. PubMed ID: 6119298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 1. URINARY EXCRETION OF INTERMEDIARY METABOLITES OF TYROSINE IN HEALTHY INDIVIDUALS AND PATIENTS WITH LIVER DISORDERS].
    AKISAWA J
    Naika Hokan; 1964 Mar; 11():85-95. PubMed ID: 14163645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders in the phenylalanine hydroxylase system of the liver in alcoholism].
    Shaposhnikov AM; Skachkov MM
    Vopr Med Khim; 1977; 23(4):495-9. PubMed ID: 919373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The labelling of urinary acids after oral doses of deuterated L-phenylalanine and L-tyrosine in normal subjects. Quantitative studies with implications for the deuterated phenylalanine load test in phenylketonuria.
    Fell V; Hoskins JA; Pollitt RJ
    Clin Chim Acta; 1978 Feb; 83(3):259-69. PubMed ID: 624181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of phenylalanine and tyrosine metabolism in Down's syndrome].
    Shaposhnikov AM; Khal'chitskiĭ SE; Shvarts EI
    Vopr Med Khim; 1979; 25(1):15-9. PubMed ID: 154771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of catecholamines by children with collagen diseases.
    Matsaniotis N; Danelatos-Athanassiadis C; Agathopoulos A; Charokopos E; Constantsas N
    Clin Chim Acta; 1968 Oct; 22(2):195-9. PubMed ID: 5303205
    [No Abstract]   [Full Text] [Related]  

  • 14. The enzymic conversion of phenylalanine to tyrosine.
    KAUFMAN S
    Biochim Biophys Acta; 1957 Feb; 23(2):445-6. PubMed ID: 13412751
    [No Abstract]   [Full Text] [Related]  

  • 15. The enzymatic conversion of phenylalanine to tyrosine.
    KAUFMAN S
    J Biol Chem; 1957 May; 226(1):511-24. PubMed ID: 13428782
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenylalanine and tyrosine metabolism in patients with phenylketonuria.
    BOSCOTT RJ; BICKEL H
    Biochem J; 1953 Oct; 56(322nd Meeting):i. PubMed ID: 13126113
    [No Abstract]   [Full Text] [Related]  

  • 17. A new cofactor required for the enzymatic conversion of phenylalanine to tyrosine.
    KAUFMAN S
    J Biol Chem; 1958 Feb; 230(2):931-9. PubMed ID: 13525410
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of intravenous phenylalanine by babies born before 33 weeks of gestation.
    Walker V; Mills GA
    Biol Neonate; 1990; 57(3-4):155-66. PubMed ID: 2108734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of phenylalanine hydroxylase of hepatoma and liver of normal and tumorous animals.
    SMIRNOVA EV
    Probl Oncol; 1961; 7():1253-60. PubMed ID: 14039356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of phenylacetylglutamine in liver diseasses].
    Mardashev SR; Debov SS; Khokhlov AP
    Sov Med; 1968 Mar; 31(3):27-30. PubMed ID: 5674168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.